No Long-Term Cognitive Effects Seen for Menopausal Hormone Therapy
No long-term cognitive effects of mHT were seen in the KEEPS Continuation study, about 10 years after completion of randomized treatment
FDA Approves Nerivio for Migraine Treatment in Children Aged 8 Years and Older
Device becomes the first and only remote electrical neuromodulation wearable for migraine treatment for children 8 years and older
Younger Patients More Affected by Neurologic Manifestations of Long COVID
Younger and middle-aged patients have higher burden of neurologic symptoms, fatigue, sleep disturbance, cognitive dysfunction
Considerable Disparities in Life Expectancy Exist Within U.S. Population
Large disparities in life expectancy observed, which grew over time, especially during the first two years of COVID-19
Recovery From Anti-NMDAR Encephalitis Continues for Three Years
34 percent of patients have persistent impairment beyond 36 months, although most have favorable outcome on mRS
Worse Outcomes Seen for Seniors With Alzheimer Disease, Dementia, Polypharmacy
Older adults with ADRD and polypharmacy experience more symptoms, have negative health outcomes
AI Model FastGlioma Can Detect Glioma Infiltration During Surgery
FastGlioma outperformed image-guided and fluorescence-guided adjuncts in a head-to-head prospective study
High Cardiorespiratory Fitness Linked to Lower Dementia Risk
For people with a moderate/high polygenic risk score, high CRF attenuates all dementia risk
Vitamin D Supplements May Lower Blood Pressure in Seniors With Overweight
Reduction seen in overall cohort and in those with BMI >30, hypertension
Disparities Identified in Telemedicine Use for Neurologic Conditions
Odds of telemedicine visit in late pandemic period lower for older adults, Blacks and Hispanics, those with higher Area Deprivation Index